Coronary Disease: all 2,867 studies
Page 29 of 29. Open to participants first (309), then studies with results posted, then the rest; newest registration first within each.
- Study of Blood Flow in Heart MuscleCompletedNCT00001631Phase 2
- Potential Role of CMV in Restenosis Following Angioplasty, in Atherosclerosis, and in Endothelial DysfunctionCompletedNCT00001531
- Study of the Interaction Between the Cells Lining Blood Vessels and Angiotensin-Converting EnzymeCompletedNCT00001461
- Analysis of Heart Muscle Function in Patients With Heart Disease and Normal VolunteersCompletedNCT00001459
- Evaluation of Patients With Known or Suspected Heart DiseaseCompletedNCT00001313
- Azithromycin and Coronary Events Study (ACES)CompletedNCT00000617Phase 3
- CVD Risk and Health in Postmenopausal Phytoestrogen UsersCompletedNCT00000613Phase 2
- Women's Health Initiative (WHI)CompletedNCT00000611Phase 3
- Magnesium in Coronaries (MAGIC)CompletedNCT00000610Phase 3
- Estrogen and Graft Atherosclerosis Research Trial (EAGER)CompletedNCT00000605Phase 3
- Influence of CPB Temperature on CABG MorbidityCompletedNCT00000604Phase 2
- Postmenopausal Hormone Therapy in Unstable AnginaCompletedNCT00000601Phase 3
- Cholesterol-Lowering Atherosclerosis Study (CLAS)CompletedNCT00000599Phase 3
- NHLBI Type II Coronary Intervention StudyCompletedNCT00000594Phase 3
- Women's Estrogen/Progestin Lipid Lowering Hormone Atherosclerosis Regression Trial (WELL-HART)CompletedNCT00000559Phase 3
- Prevention of Events With Angiotensin-Converting Enzyme Inhibitor Therapy (PEACE)CompletedNCT00000558Phase 3
- Enhancing Recovery in Coronary Heart Disease (ENRICHD) PatientsCompletedNCT00000557Phase 3
- Women's Angiographic Vitamin and Estrogen Trial (WAVE)CompletedNCT00000555Phase 3
- Women's Ischemia Syndrome Evaluation (WISE)CompletedNCT00000554Phase 3
- HDL-Atherosclerosis Treatment Study (HATS)CompletedNCT00000553Phase 3
- Shock Trial: Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.CompletedNCT00000552Phase 3
- Rapid Early Action for Coronary Treatment (REACT)CompletedNCT00000550Phase 3
- Estrogen Replacement and Atherosclerosis (ERA) in Older WomenCompletedNCT00000549Phase 3
- Stress Reduction and Atherosclerotic CVD in BlacksCompletedNCT00000546Phase 3
- Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)CompletedNCT00000542Phase 3
- Women's Antioxidant and Folic Acid Cardiovascular Study (WAFACS)CompletedNCT00000541Phase 2
- Coronary Artery Bypass Graft (CABG) Patch TrialCompletedNCT00000540Phase 3
- Dietary Effects on Lipoproteins and Thrombogenic ActivityCompletedNCT00000538Phase 3
- Montreal Heart Attack Readjustment Trial (M-HART)CompletedNCT00000533Phase 3
- Tamoxifen StudyCompletedNCT00000529Phase 3
- Cardiac Arrhythmia Suppression Trial (CAST)CompletedNCT00000526Phase 3
- Optimal Exercise Regimens for Persons at Increased RiskCompletedNCT00000523Phase 2
- Exercise Training and Plasma Lipoproteins in ManCompletedNCT00000519Phase 3
- Studies of Left Ventricular Dysfunction (SOLVD)CompletedNCT00000516Phase 3
- Familial Atherosclerosis Treatment StudyCompletedNCT00000512Phase 3
- Platelet-Inhibitor Drug Trial in Coronary AngioplastyCompletedNCT00000510Phase 3
- Stanford Coronary Risk Intervention Project (SCRIP)CompletedNCT00000508Phase 3
- Intravenous Streptokinase in Acute Myocardial InfarctionCompletedNCT00000507Phase 3
- Thrombolysis in Myocardial Infarction (TIMI)CompletedNCT00000505Phase 3
- Randomized Clinical Trial of Non-Surgical Reperfusion of the Coronary ArteriesCompletedNCT00000503Phase 3
- Physicians' Health StudyCompletedNCT00000500Phase 3
- Platelet Drug Trial in Coronary Disease ProgressionCompletedNCT00000496Phase 3
- Multicenter Investigation of Limitation of Infarct Size (MILIS)CompletedNCT00000493Phase 3
- Beta-Blocker Heart Attack Trial (BHAT)CompletedNCT00000492Phase 3
- Aspirin-Myocardial Infarction Study (AMIS)CompletedNCT00000491Phase 3
- Program on Surgical Control of Hyperlipidemias (POSCH)CompletedNCT00000490Phase 3
- Coronary Artery Surgery Study (CASS)CompletedNCT00000489Phase 3
- Lipid Research Clinics Coronary Primary Prevention Trial (CPPT)CompletedNCT00000488Phase 3
- Multiple Risk Factor Intervention Trial for the Prevention of Coronary Heart Disease (MRFIT)CompletedNCT00000487Phase 3
- Unstable Angina Pectoris TrialCompletedNCT00000486Phase 3
- Coronary Drug Project Mortality SurveillanceCompletedNCT00000483Not applicable
- Coronary Drug ProjectCompletedNCT00000482Phase 3
- Women's Health Trial: Feasibility Study in Minority PopulationsCompletedNCT00000481Phase 3
- Multicenter Unsustained Tachycardia Trial (MUSTT)CompletedNCT00000480Phase 3
- Asymptomatic Cardiac Ischemia Pilot (ACIP) StudyCompletedNCT00000478Phase 3
- Cholesterol Reduction in Seniors Program (CRISP)CompletedNCT00000477Phase 2
- Do Fish Oils Prevent Restenosis Post-Coronary Angioplasty?CompletedNCT00000473Phase 3
- Thrombolysis in Myocardial Ischemia Trial (TIMI III)CompletedNCT00000472Phase 3
- Lifestyle Heart TrialCompletedNCT00000471Phase 2
- Myocardial Infarction Triage and Intervention Project (MITI)CompletedNCT00000468Phase 3
- Postmenopausal Estrogen/Progestin Interventions (PEPI)CompletedNCT00000466Phase 3
- Emory Angioplasty Versus Surgery Trial (EAST)CompletedNCT00000465Phase 3
- Post Coronary Artery Bypass Graft (CABG) StudyCompletedNCT00000463Phase 3
- Bypass Angioplasty Revascularization Investigation (BARI)CompletedNCT00000462Phase 3
- Harvard Atherosclerosis Reversibility Project (HARP)CompletedNCT00000461Phase 2
- Training Levels Comparison TrialWithdrawnNCT00000460
- Effects of Training Intensity on the CHD Risk Factors in Postmenopausal WomenCompletedNCT00000108Not applicable